Prince Harry Stir Controversy: Fans React to Royal Remarks on Spare Drug Confession

LONDON – Prince Harry’s recent remarks concerning his royal status have ignited a wave of scrutiny and debate among fans. The lawyer’s comments on Harry’s supposed confession about using drugs during his youth have only added to the controversy. As fans question the prince’s intentions and credibility, the conversation around his statements continues to unfold. The prince’s remarks, made during an interview, have triggered speculation about his true sentiments towards the royal family. Many fans are questioning whether Harry’s decision to step back from his royal duties was influenced by a desire to distance himself … Read more

Northern California Syndicate Members Convicted for Multi-Million Dollar Drug Operation, Including Fentanyl and Cocaine Seizures

SAN FRANCISCO, California – Three members of syndicates in Northern California have been convicted of multiple narcotics offenses after an eight-day trial, according to the U.S. Attorney’s Office. The trial presented evidence from intercepted calls between April 2018 and February 2019 as part of a federal wiretap investigation into two drug suppliers in the East Bay. The intercepted calls revealed that the suppliers obtained drugs from sources in Mexico. Federal prosecutors showcased several significant drug seizures as evidence, including 8.8 pounds of fentanyl and heroin valued at up to $1.1 million, 18 pounds of methamphetamine, … Read more

Federal Judge Dismisses PhRMA’s Lawsuit Against Biden’s Drug Price-Setting Provisions

WASHINGTON (AP) – The US trade group Pharmaceutical Research and Manufacturers of America (PhRMA) faced a setback in its efforts to oppose drug price-setting provisions in the Biden administration’s Inflation Reduction Act (IRA). A federal judge in the District Court for the Western District of Texas has thrown out PhRMA’s lawsuit on Monday, dealing a blow to their attempts to halt the price-curbing measures. PhRMA has been vocal in its opposition to the IRA, asserting concerns over the impact of price-setting on the pharmaceutical industry. However, their legal challenge has been dismissed by the court, … Read more

Federal Judge Dismisses Pharmaceutical Industry Lawsuit Over Medicare Drug Pricing Program

Austin, Texas – A federal judge in Austin has dismissed a lawsuit brought by pharmaceutical industry bodies challenging a new Medicare program that allows the government to negotiate prices for expensive drugs. U.S. District Judge David Ezra, appointed by Ronald Reagan, sided with the Biden administration in throwing out the lawsuit. The Pharmaceutical Research and Manufacturers of America (PhRMA) group and two others had claimed the program was unconstitutional. Under the program, known as the Inflation Reduction Act, the Department of Health and Human Services is authorized to seek lower prices for certain drugs, ultimately … Read more